245 related articles for article (PubMed ID: 17854144)
1. Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters.
Iwaki T; Ishizaki K; Kinoshita S; Tanaka H; Fukunari A; Tsurufuji M; Imada T
World J Gastroenterol; 2007 Oct; 13(37):5003-8. PubMed ID: 17854144
[TBL] [Abstract][Full Text] [Related]
2. Effect of ursodeoxycholic acid on hepatic LDL binding and uptake in dietary hypercholesterolemic hamsters.
Ceryak S; Bouscarel B; Malavolti M; Robins SJ; Caslow KL; Fromm H
Atherosclerosis; 2000 Nov; 153(1):59-67. PubMed ID: 11058700
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of bile salts against biliary epithelium: a study in isolated bile ductule fragments and isolated perfused rat liver.
Benedetti A; Alvaro D; Bassotti C; Gigliozzi A; Ferretti G; La Rosa T; Di Sario A; Baiocchi L; Jezequel AM
Hepatology; 1997 Jul; 26(1):9-21. PubMed ID: 9214446
[TBL] [Abstract][Full Text] [Related]
4. Changes in bile acid composition and effect on cytolytic activity of fecal water by ursodeoxycholic acid administration: a placebo-controlled cross-over intervention trial in healthy volunteers.
van Gorkom BA; van der Meer R; Boersma-van Ek W; Termont DS; de Vries EG; Kleibeuker JH
Scand J Gastroenterol; 2002 Aug; 37(8):965-71. PubMed ID: 12229974
[TBL] [Abstract][Full Text] [Related]
5. Suppression of renal disease and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus (SLE) by chenodeoxycholic acid.
Suwannaroj S; Lagoo A; McMurray RW
Lupus; 2001; 10(8):562-7. PubMed ID: 11530998
[TBL] [Abstract][Full Text] [Related]
6. Effect of bile acids on absorption of nitrendipine in healthy subjects.
Sasaki M; Maeda A; Sakamoto K; Fujimura A
Br J Clin Pharmacol; 2001 Dec; 52(6):699-701. PubMed ID: 11736882
[TBL] [Abstract][Full Text] [Related]
7. Effects of ursodeoxycholic acid and chenodeoxycholic acid on human hepatocytes in primary culture.
Hillaire S; Ballet F; Franco D; Setchell KD; Poupon R
Hepatology; 1995 Jul; 22(1):82-7. PubMed ID: 7601437
[TBL] [Abstract][Full Text] [Related]
8. Effect of oral ursodeoxycholic acid on bile acids tolerance tests in healthy dogs.
Abraham LA; Charles JA; Holloway SA
Aust Vet J; 2004 Mar; 82(3):157-60. PubMed ID: 15088982
[TBL] [Abstract][Full Text] [Related]
9. Studies on the mechanism of the ursodeoxycholic acid-induced increase in hepatic low-density lipoprotein binding.
Bouscarel B; Ceryak S; Robins SJ; Fromm H
Lipids; 1995 Jul; 30(7):607-17. PubMed ID: 7564915
[TBL] [Abstract][Full Text] [Related]
10. Effect of ursodeoxycholic acid administration on bile acid composition in hamster bile.
Matejka M; Vescina C; Carducci CN; Alayón A; Dios A; Scarlatto E; Mamianetti A
Pharmacol Res; 1990; 22(3):297-305. PubMed ID: 2367280
[TBL] [Abstract][Full Text] [Related]
11. Hydrophilic but not hydrophobic bile acids prevent gallbladder muscle dysfunction in acute cholecystitis.
Xiao ZL; Biancani P; Carey MC; Behar J
Hepatology; 2003 Jun; 37(6):1442-50. PubMed ID: 12774024
[TBL] [Abstract][Full Text] [Related]
12. A novel, protective role of ursodeoxycholate in bile-induced pancreatic ductal injury.
Katona M; Hegyi P; Kui B; Balla Z; Rakonczay Z; Rázga Z; Tiszlavicz L; Maléth J; Venglovecz V
Am J Physiol Gastrointest Liver Physiol; 2016 Feb; 310(3):G193-204. PubMed ID: 26608189
[TBL] [Abstract][Full Text] [Related]
13. Biliary bile acids in primary biliary cirrhosis: effect of ursodeoxycholic acid.
Combes B; Carithers RL; Maddrey WC; Munoz S; Garcia-Tsao G; Bonner GF; Boyer JL; Luketic VA; Shiffman ML; Peters MG; White H; Zetterman RK; Risser R; Rossi SS; Hofmann AF
Hepatology; 1999 Jun; 29(6):1649-54. PubMed ID: 10347103
[TBL] [Abstract][Full Text] [Related]
14. Ursodeoxycholic acid inhibits hepatic cystogenesis in experimental models of polycystic liver disease.
Munoz-Garrido P; Marin JJ; Perugorria MJ; Urribarri AD; Erice O; Sáez E; Úriz M; Sarvide S; Portu A; Concepcion AR; Romero MR; Monte MJ; Santos-Laso Á; Hijona E; Jimenez-Agüero R; Marzioni M; Beuers U; Masyuk TV; LaRusso NF; Prieto J; Bujanda L; Drenth JP; Banales JM
J Hepatol; 2015 Oct; 63(4):952-61. PubMed ID: 26044126
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholic Acid Ameliorates Intrahepatic Cholestasis Independent of Biliary Bicarbonate Secretion in Vil2
Hatano R; Kawaguchi K; Togashi F; Sugata M; Masuda S; Asano S
Biol Pharm Bull; 2017; 40(1):34-42. PubMed ID: 28049946
[TBL] [Abstract][Full Text] [Related]
16. Effects of selective zonal injury on bile acid-induced bile flow in the isolated rat liver.
Monte MJ; Badia MD; Palomero F; el-Mir MY; Alonso JR; Marin JJ
Am J Physiol; 1993 Jun; 264(6 Pt 1):G1103-11. PubMed ID: 8333538
[TBL] [Abstract][Full Text] [Related]
17. Effects of specific bile acids on c-fos messenger RNA levels in human colon carcinoma Caco-2 cells.
Di Toro R; Campana G; Murari G; Spampinato S
Eur J Pharm Sci; 2000 Oct; 11(4):291-8. PubMed ID: 11033072
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholic acid protects concanavalin A-induced mouse liver injury through inhibition of intrahepatic tumor necrosis factor-alpha and macrophage inflammatory protein-2 production.
Ishizaki K; Iwaki T; Kinoshita S; Koyama M; Fukunari A; Tanaka H; Tsurufuji M; Sakata K; Maeda Y; Imada T; Chiba K
Eur J Pharmacol; 2008 Jan; 578(1):57-64. PubMed ID: 17888421
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity of bile acids in rabbits: ursodeoxycholic acid is less toxic than chenodeoxycholic acid.
Miyai K; Javitt NB; Gochman N; Jones HM; Baker D
Lab Invest; 1982 Apr; 46(4):428-37. PubMed ID: 7200166
[TBL] [Abstract][Full Text] [Related]
20. Morphologic changes in livers of hamsters treated with high doses of ursodeoxycholic acid: correlation with bile acids in bile.
Mamianetti A; Konopka HF; Lago N; Vescina C; Scarlato E; Carducci CN
Pharmacol Res; 1994; 29(2):187-95. PubMed ID: 8058592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]